Suzuken Co Ltd
TSE:9987
Intrinsic Value
The intrinsic value of one Suzuken Co Ltd stock under the Base Case scenario is 8 475 JPY. Compared to the current market price of 3 275 JPY, Suzuken Co Ltd is Undervalued by 61%.
The Intrinsic Value is calculated as the average of the two valuation methods:
Fundamental Analysis
Profitability Score
Profitability Due Diligence
Suzuken Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
Suzuken Co Ltd's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Suzuken Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Suzuken Co Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Balance Sheet Decomposition
Suzuken Co Ltd
| Current Assets | 1T |
| Cash & Short-Term Investments | 251B |
| Receivables | 585B |
| Other Current Assets | 196B |
| Non-Current Assets | 272B |
| Long-Term Investments | 93.4B |
| PP&E | 128B |
| Intangibles | 10.9B |
| Other Non-Current Assets | 39.8B |
| Current Liabilities | 865B |
| Accounts Payable | 824B |
| Accrued Liabilities | 5.1B |
| Other Current Liabilities | 35.7B |
| Non-Current Liabilities | 26.7B |
| Other Non-Current Liabilities | 26.7B |
Capital Structure
Suzuken Co Ltd
| Market Capitalization | 271B JPY | |
| Total Debt | 0 JPY | |
| Minority Interest | 299M JPY | |
| Preferred Equity | 0 JPY | |
| Cash and Equivalents | 170B JPY | |
| Short-Term Investments | 81.2B JPY | |
| Enterprise Value | 20.3B JPY | |
Wall St
Price Targets
Price Targets Summary
Suzuken Co Ltd
According to Wall Street analysts, the average 1-year price target for Suzuken Co Ltd is 4 105.5 JPY with a low forecast of 3 535 JPY and a high forecast of 5 040 JPY.
Shareholder Return
Return Decomposition
Main factors of price return
Market capitalization of Suzuken Co Ltd shares decreased by 29.04% over the past 5 years. The primary factor behind the change was a decrease in P/E multiple from 20.3 to 14, leading to a drop in the market capitalization of Suzuken Co Ltd by 31.21%.
Market capitalization of Suzuken Co Ltd shares decreased by 29.04% over the past 5 years. The primary factor behind the change was a decrease in P/E multiple from 20.3 to 14, leading to a drop in the market capitalization of Suzuken Co Ltd by 31.21%.
Price
Suzuken Co Ltd
| Average Annual Return | -2.48% |
| Standard Deviation of Annual Returns | 24.64% |
| Max Drawdown | -55% |
| Market Capitalization | 271B JPY |
| Shares Outstanding | 82 731 904 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Suzuken Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Nagoya, Aichi-Ken and currently employs 15,041 full-time employees. The firm operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
Contact
IPO
Employees
Officers
The intrinsic value of one Suzuken Co Ltd stock under the Base Case scenario is 8 475 JPY.
Compared to the current market price of 3 275 JPY, Suzuken Co Ltd is Undervalued by 61%.
